Tachosil® medicated sponge (haemostasis in surgery)
Formulary
To be used in accordance with a local Trust-approved guideline
For supportive treatment in surgery for improvement of haemostasis where standard techniques are insufficient
Tachosil® medicated sponge (sealing of the dura mater in neurosurgery)
Formulary
To be used in accordance with a local Trust-approved guideline
For supportive treatment in neurosurgery, including supportive sealing of the dura mater to prevent postoperative cerebrospinal fluid leakage.
TauroLock® catheter lock solution
Formulary
For patients receiving long term, home parenteral nutrition who have experienced one episode of confirmed catheter-related blood stream infection (CRBSI)
TauroLock® HEP500 catheter lock solution
Formulary
Restricted as second-line alternative to trisodium citrate 46.7% for patients
Who are IVDUs or
Can not tolerate high levels of citrate, or
In dialysis patients with recurrent bacteraemia
Trisodium citrate 46.7% catheter lock solution
Formulary
Antimicrobial and anticoagulant catheter locking solution for central venous catheters used in renal dialysis patients
Specialist or hospital prescribing only.
The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital.
In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.
Treatment can be initiated in primary care after a recommendation from an appropriate specialist
Specialist initiation followed by maintenance prescribing in primary care
Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation